Skip to content

Malleable Single Stage Venous Cannula with Carmeda Bioactive Surface, Model CB681XX Series

by Medtronic Perfusion Systems

510(k) K033264

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK033264 Date31 Oct 2003ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-1924-2008 FDA Unclassified (pre-2012) initiated 9 May 2008

    Medtronic is recalling selected Carmeda-coated cardiopulmonary bypass (CPB) products (e.g., oxygenators, reservoirs, pumps, cannulae and tubing packs) that were manufactured with contaminated heparin. Medtronic's heparin supplier recently reported that it had provided some batches to Medtronic that were contaminated with oversulfated chondroitin sulfate (OSCS).

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DWF
Device Class
Class II
Regulation
21 CFR Part 870.4210
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a vascular catheter, cannula, and tubing for cardiopulmonary bypass, classified under product code DWF. It features a malleable single-stage venous cannula with a Carmeda bioactive surface, designed to facilitate venous drainage during extracorporeal circulation procedures. The bioactive coating is intended to enhance biocompatibility and reduce thrombogenic risks, supporting safe and effective perfusion during cardiac surgeries.

The cannula is single-use and intended for sterile use in controlled clinical settings, such as operating rooms or cardiac catheterization labs. It is not MRI-safe and must be handled with sterile technique prior to use. Available in the CB681XX series, the device is FDA-cleared under 510(k) K033264 as substantially equivalent to its predicate device. Storage and handling must comply with manufacturer guidelines to maintain sterility and performance.

Other devices from Medtronic Perfusion Systems

See all devices from Medtronic Perfusion Systems →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the CB681XX venous cannula designed for?

    The Medtronic CB681XX malleable single-stage venous cannula is specifically designed for venous drainage during cardiopulmonary bypass procedures. Its Carmeda bioactive surface helps enhance biocompatibility and minimize the risk of clotting, ensuring safer and more effective perfusion during cardiac surgeries. This makes it ideal for use in operating rooms or cardiac catheterization labs where extracorporeal circulation is required.

  • Is the CB681XX cannula single-use or reusable?

    The CB681XX venous cannula is intended for single-use only. This design choice aligns with clinical best practices for maintaining sterility and reducing infection risks in sensitive procedures like cardiopulmonary bypass. Always follow manufacturer guidelines to ensure proper handling and disposal after a single use.

  • How should the CB681XX cannula be stored to maintain sterility?

    The CB681XX cannula must be stored according to Medtronic’s guidelines to preserve its sterility and performance. It is packaged for sterile use, so it should remain in its original, unopened packaging until immediately before use. Exposure to moisture, contamination, or improper handling can compromise sterility, so always store it in a clean, dry environment away from direct sunlight or extreme temperatures.

  • What distinguishes the Carmeda bioactive surface on this cannula?

    The Carmeda bioactive surface on the CB681XX cannula is engineered to improve biocompatibility by reducing the body’s adverse response to the foreign material. This coating helps lower the risk of thrombogenic events—such as clot formation—during prolonged use in cardiopulmonary bypass. The result is a safer perfusion experience for patients undergoing cardiac surgeries, as it minimizes complications associated with blood contact.

  • Are there different sizes or models within the CB681XX series?

    The CB681XX series includes multiple models, each tailored to specific patient needs and procedural requirements. While the exact sizes or variations are not detailed in the provided data, the series is designed to accommodate different venous access scenarios during cardiopulmonary bypass. Always refer to the manufacturer’s documentation or consult with a clinical specialist to select the appropriate model for your patient’s anatomy and surgical plan.